跳至主要内容
临床试验/NCT01362504
NCT01362504已完成不适用

Zekai Tahir Burak Maternity Teaching Hospital Neonatal Intensive Care Unit

Zekai Tahir Burak Women's Health Research and Education Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80
试验地点
1

研究概览

简要总结

The aim of this study was to clarify the prognostic value of serum pro-Adrenomedullin level in neonatal sepsis. Eighty term and preterm neonates with sepsis were enrolled in this study. Eighty healthy matched neonates served as a control group.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
24 Weeks 至 42 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Clinical sepsis and/or proven sepsis.

排除标准

  • Acute kidney injury
  • Intracranial hemorrhage (Grade III and IV)

研究者

发起方
Zekai Tahir Burak Women's Health Research and Education Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mehmet Yekta

Zekai Tahir Burak Maternity and Teaching Hospital

Zekai Tahir Burak Women's Health Research and Education Hospital

研究点 (1)

Loading locations...

相似试验